Exelixis | Zysk Brutto



Pre Tax Profit Zmiana Data
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Agios Pharmaceuticals USD -105399000 1.11B 2024-12
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 1.67B 162M 2024-12
Bayer EUR -481000000 805M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 4.26B 226M 2024-12
Cytokinetics USD -150020000 10.52M 2024-12
Eisai JPY 29.55B 13.99B 2024-12
Eli Lilly USD 5.54B 3.83B 2024-12
Exelixis USD 184.77M 30.02M 2024-12
Genmab DKK 3.6B 1.88B 2024-12
Glaxosmithkline USD 1.66B 1.78B 2024-12
Incyte USD 406.83M 147.12M 2024-12
Ionis Pharmaceuticals USD -107000000 37M 2024-12
MacroGenics USD 56.31M 111.97M 2024-09
Merck USD 5.22B 114M 2024-12
Moderna USD -1184000000 1.2B 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Sanofi USD 2.32B 2.64B 2024-12
Takeda JPY 26.41B 92.96B 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Xencor USD -52626000 6.33M 2024-12



Exelixis Zysk Brutto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.